Application Nr Approved Date Route Status External Links
NDA020364 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lotrel Is A Combination Capsule Of Amlodipine, A Dihydropyridine Calcium Channel Blocker (Dhp Ccb) And Benazepril, An Angiotensin-Converting Enzyme (Ace) Inhibitor. Lotrel Is Indicated For The Treatment Of Hypertension In Patients Not Adequately Controlled On Monotherapy With Either Agent. ( 1 ) 1.1 Hypertension Lotrel Is Indicated For The Treatment Of Hypertension In Patients Not Adequately Controlled On Monotherapy With Either Agent.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments